Alembic Pharmaceuticals Limited's latest marketcap:
As of 08/13/2025, Alembic Pharmaceuticals Limited's market capitalization has reached $2.13 B. According to our data, Alembic Pharmaceuticals Limited is the 6174th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 2.13 B |
| Revenue (ttm) | 780.25 M |
| Net Income (ttm) | 68.99 M |
| Shares Out | 196.56 M |
| EPS (ttm) | 0.35 |
| Forward PE | 24.70 |
| Ex-Dividend Date | 07/29/2025 |
| Earnings Date | 08/04/2025 |
Alembic Pharmaceuticals Limited's yearly market capitalization.
| Date | Market Cap(₹) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/13/2025 | ₹186.24 B | $2.13 B | -11.14% | 6174 |
| 12/31/2024 | ₹209.59 B | $2.45 B | 40.41% | 4996 |
| 12/29/2023 | ₹149.27 B | $1.79 B | 32.55% | 6030 |
| 12/30/2022 | ₹112.61 B | $1.36 B | -28.56% | 6839 |
| 12/31/2021 | ₹157.62 B | $2.12 B | -22.43% | 5925 |
| 12/31/2020 | ₹203.2 B | $2.78 B | 88.67% | 4346 |
| 12/31/2019 | ₹107.7 B | $1.51 B | -4.74% | 5407 |
| 12/31/2018 | ₹113.06 B | $1.62 B | 13.02% | 4580 |
| 12/29/2017 | ₹100.03 B | $1.57 B | -10.84% | 5365 |
| 12/30/2016 | ₹112.19 B | $1.65 B | -14.5% | 4540 |
Company Profile
About Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is a leading pharmaceutical company engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical products. With a strong presence in India and international markets, the company delivers high-quality healthcare solutions.
Product Portfolio
- Branded Specialty Medicines: Covers therapeutic areas such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infectives, cold and cough, veterinary, and anti-diabetic treatments.
- Generic Formulations: Includes oral solids, oncology oral solids and injectables, general injectables, ophthalmic products, dermatology solutions, and oral suspensions.
- Active Pharmaceutical Ingredients (APIs): Supplies high-quality APIs for pharmaceutical manufacturing.
Global Reach
The company exports its products worldwide, ensuring access to affordable and effective medicines in multiple markets.
Company Background
Founded in 1907, Alembic Pharmaceuticals is headquartered in Vadodara, India, and has built a legacy of innovation and excellence in the pharmaceutical industry.
Frequently Asked Questions
-
What is Alembic Pharmaceuticals Limited's (NSE-APLLTD) current market cap?As of 08/13/2025, Alembic Pharmaceuticals Limited (including the parent company, if applicable) has an estimated market capitalization of $2.13 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Alembic Pharmaceuticals Limited (NSE-APLLTD) rank globally by market cap?Alembic Pharmaceuticals Limited global market capitalization ranking is approximately 6174 as of 08/13/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.